Inactive Instrument

Sector Chart Viracta Therapeutics, Inc. Nasdaq

Equities

US92765F1084

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
42.12B
42.05B
29.18B
26.02B
18.9B -
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW